Replies to post #300153 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Also, the expanded and unblinded compassionate use arm that Alexander pointed to were patients with a terrible prognosis. They were not in the blind trial, because they did not qualify, but they did exceptionally well on DCVax-L, which also contradicts the allegation.